Clinical pharmacological studies in tuberculosis patients: ‘Research from the Kilimanjaro Region,Tanzania’
Year: 2014
Type: dissertation
Study design: Observational Study
Abstract: Chapter 6: Changes in lifestyle and diet have contributed to an increased prevalence of diabetes in many low-income and middle-income countries where the burden of TB is high.Diabetes triples the risk of developing TB consequently; rates of TB are higher in people with diabetes than in the general population.In addition, TB patients with DM show a worse response to TB treatment compared to non-diabetics.This may result from differences in pharmacokinetics of TB drugs between diabetics and non-diabetics.This chapter describes a pharmacokinetic study in patients with TB alone and TB with DM as concurrent disease.Chapter 7: This chapter describes a survey conducted in Tanzanian TB patients to find out the incidence of TB drugs induced hepatotoxicity in Tanzania.Chapter 8: This is divided in two sections.In chapter 8(a), the rate of fluoroquinolones sale for the treatment of other infections, which may cause their effectiveness against TB to be lost, is evaluated in an antimicrobial drug surveillance in the Moshi area.Then in chapter 8(b), the research question is whether fluoroquinolones resistance in M. tuberculosis is common in Tanzanian TB patients, considering the availability of fluoroquinolones in the general population.Chapter 9: This chapter discusses the findings from the above studies and implications of the findings in solving pharmacological concerns about anti-TB drugs.Furthermore, recommendations for further research are highlighted.
Author: Hadija Semvua
Institution: Radboud University Nijmegen
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W766658980
